Evan Hall

1.3k total citations
51 papers, 653 citations indexed

About

Evan Hall is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Evan Hall has authored 51 papers receiving a total of 653 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Oncology, 10 papers in Pulmonary and Respiratory Medicine and 7 papers in Immunology. Recurrent topics in Evan Hall's work include Polyomavirus and related diseases (12 papers), Cancer Immunotherapy and Biomarkers (11 papers) and Renal cell carcinoma treatment (8 papers). Evan Hall is often cited by papers focused on Polyomavirus and related diseases (12 papers), Cancer Immunotherapy and Biomarkers (11 papers) and Renal cell carcinoma treatment (8 papers). Evan Hall collaborates with scholars based in United States, South Africa and United Kingdom. Evan Hall's co-authors include Shailender Bhatia, Scott S. Tykodi, Tanya Gupta, James M. Ford, Alexandra Lebensohn, Meredith Mills, Kerry Kingham, Iva Petrovchich, Andrew J. Portuguese and Jennifer L. Caswell‐Jin and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Evan Hall

43 papers receiving 643 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Evan Hall United States	13	233	145	131	127	83	51	653
Sachin R. Jhawar United States	14	245 1.1×	184 1.3×	63 0.5×	122 1.0×	109 1.3×	84	755
Steven R. Sloan United States	19	200 0.9×	183 1.3×	144 1.1×	142 1.1×	71 0.9×	58	1.4k
Su Yon Jung United States	11	194 0.8×	133 0.9×	117 0.9×	82 0.6×	71 0.9×	65	607
Lou Gonsalves United States	16	455 2.0×	99 0.7×	133 1.0×	90 0.7×	143 1.7×	30	781
Wendy Bannister United Kingdom	15	332 1.4×	217 1.5×	124 0.9×	198 1.6×	69 0.8×	29	938
Ido Laskov Israel	15	212 0.9×	215 1.5×	69 0.5×	46 0.4×	44 0.5×	59	652
Jagannath Dev Sharma India	17	228 1.0×	356 2.5×	73 0.6×	64 0.5×	106 1.3×	72	789
Miriam Mutebi Kenya	14	353 1.5×	94 0.6×	145 1.1×	43 0.3×	52 0.6×	45	679
Jillian H. Hurst United States	18	105 0.5×	380 2.6×	123 0.9×	46 0.4×	110 1.3×	61	811
Suzanne Tavitian France	14	130 0.6×	200 1.4×	62 0.5×	81 0.6×	56 0.7×	59	857

Countries citing papers authored by Evan Hall

Since Specialization

Citations

This map shows the geographic impact of Evan Hall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Evan Hall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Evan Hall more than expected).

Fields of papers citing papers by Evan Hall

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Evan Hall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Evan Hall. The network helps show where Evan Hall may publish in the future.

Co-authorship network of co-authors of Evan Hall

This figure shows the co-authorship network connecting the top 25 collaborators of Evan Hall. A scholar is included among the top collaborators of Evan Hall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Evan Hall. Evan Hall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hippe, Daniel S., Tomoko Akaike, Natalie J. Miller, et al.. (2025). Real-world outcomes of patients receiving salvage therapies for immune checkpoint inhibitor-resistant Merkel cell carcinoma: a rationale for future clinical trials. Journal for ImmunoTherapy of Cancer. 13(9). e012660–e012660.

Wallner, Kent, et al.. (2025). Simultaneous conjunctival melanomas in one eye treated with both adjuvant brachytherapy and proton beam radiotherapy. American Journal of Ophthalmology Case Reports. 38. 102281–102281.

Tretiakova, Maria, et al.. (2024). Metastatic SMARCB1-Deficient Renal Medullary Carcinoma without Hemoglobinopathy with Durable and Dramatic Response to Pembrolizumab plus Lenvatinib: Case Report. SHILAP Revista de lepidopterología. 17(1). 1025–1033. 1 indexed citations

Miller, Natalie J., Wenwen Chen, Evan Hall, et al.. (2024). TRICK-MCC: A proof-of-concept, investigator-initiated study of combination therapy with anti–PD-1, anti–LAG-3, and anti–TIM-3 in participants with advanced or metastatic PD-(L)1 refractory Merkel cell carcinoma.. Journal of Clinical Oncology. 42(16_suppl). TPS9618–TPS9618.

Jonasch, Eric, Bradley A. McGregor, Pavlos Msaouel, et al.. (2024). 1690O NKT2152, a novel oral HIF-2α inhibitor, in participants (pts) with previously treated advanced clear cell renal carcinoma (accRCC): Preliminary results of a phase I/II study. Annals of Oncology. 35. S1011–S1012. 4 indexed citations

Hall, Evan, Raquibul Hannan, Jay J. Liao, et al.. (2024). Focal therapy for oligometastatic and oligoprogressive renal cell carcinoma: a narrative review. Future Oncology. 20(33). 2573–2588. 4 indexed citations

Barbour, Andrew B., Simon Kirste, Shankar Siva, et al.. (2023). The Judicious Use of Stereotactic Ablative Radiotherapy in the Primary Management of Localized Renal Cell Carcinoma. Cancers. 15(14). 3672–3672. 2 indexed citations

Miller, Natalie, Jacob B. Leary, Joshua Veatch, et al.. (2023). 819 Concurrent treatment with GM-CSF immunoembolization of hepatic metastases and systemic immune checkpoint inhibitors to overcome immune evasion in patients with metastatic uveal melanoma. SHILAP Revista de lepidopterología. A917–A917.

Tachiki, Lisa, Daniel S. Hippe, Evan Hall, et al.. (2023). Extended duration of treatment using reduced-frequency dosing of anti-PD-1 therapy in patients with advanced melanoma and Merkel cell carcinoma. Cancer Immunology Immunotherapy. 72(11). 3839–3850. 9 indexed citations

10.

Wojcik, Katherine Y., Evan Hall, Ashley Wysong, et al.. (2023). Melanoma survival by age group: Population-based disparities for adolescent and young adult patients by stage, tumor thickness, and insurance type. Journal of the American Academy of Dermatology. 88(4). 831–840. 9 indexed citations

11.

Jonasch, Eric, Ralph J. Hauke, Gerald S. Falchook, et al.. (2023). A Phase 1/2, open label dose-escalation and expansion trial of NKT2152, an orally administered HIF2α inhibitor, to investigate safety, PK, PD and clinical activity in patients with advanced ccRCC. The Oncologist. 28(Supplement_1). S12–S12. 1 indexed citations

12.

Akaike, Tomoko, Daniel S. Hippe, Michi M. Shinohara, et al.. (2022). Management and Prognosis of Cardiac Metastatic Merkel Cell Carcinoma: A Case–Control Study and Literature Review. Cancers. 14(23). 5914–5914.

13.

Portuguese, Andrew J., Jordan Gauthier, Scott S. Tykodi, et al.. (2022). CD19 CAR-T therapy in solid organ transplant recipients: case report and systematic review. Bone Marrow Transplantation. 58(4). 353–359. 16 indexed citations

14.

Griggs, Jennifer J., Kari Bohlke, Edward P. Balaban, et al.. (2021). Appropriate Systemic Therapy Dosing for Obese Adult Patients With Cancer: ASCO Guideline Update. Journal of Clinical Oncology. 39(18). 2037–2048. 75 indexed citations

15.

Goff, Peter H., et al.. (2021). Intersection of Two Checkpoints: Could Inhibiting the DNA Damage Response Checkpoint Rescue Immune Checkpoint-Refractory Cancer?. Cancers. 13(14). 3415–3415. 16 indexed citations

16.

Henson, Cynthia A., et al.. (2021). Description and functional analysis of the transcriptome from malting barley. Genomics. 113(5). 3310–3324. 11 indexed citations

17.

Akaike, Tomoko, Kristina Lachance, Aline Simoneti Fonseca, et al.. (2021). 675 Utility of circulating tumor DNA testing in Merkel cell carcinoma patients. Journal of Investigative Dermatology. 141(5). S117–S117. 1 indexed citations

18.

Hall, Evan, et al.. (2020). Perceptions of time spent pursuing cancer care among patients, caregivers, and oncology professionals. Supportive Care in Cancer. 29(5). 2493–2500. 16 indexed citations

19.

Zheng, Xiaoyi, Fariborz Soroush, Jin Long, et al.. (2017). Murine glomerular transcriptome links endothelial cell-specific molecule-1 deficiency with susceptibility to diabetic nephropathy. PLoS ONE. 12(9). e0185250–e0185250. 20 indexed citations

20.

Kapadnis, Prashant B., Evan Hall, Madeleine Ramstedt, et al.. (2008). Towards quorum-quenching catalytic antibodies. Chemical Communications. 538–540. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact